Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-474,900
Closed -$14.4M 5088
2025
Q4
$14.4M Buy
474,900
+449,900
+1,800% +$11M ﹤0.01% 1436
2025
Q3
$495K Buy
+25,000
New +$523K ﹤0.01% 3818
2025
Q2
Sell
-166,200
Closed -$3.9M 5287
2025
Q1
$3.9M Buy
+166,200
New +$4.81M ﹤0.01% 2112
2024
Q4
Sell
-63,300
Closed -$1.29M 5296
2024
Q3
$1.29M Buy
+63,300
New +$1.42M ﹤0.01% 3182
2024
Q2
Sell
-83,800
Closed -$2.56M 4917
2024
Q1
$2.56M Buy
83,800
+5,900
+8% +$167K ﹤0.01% 2365
2023
Q4
$1.82M Sell
77,900
-204,500
-72% -$4.94M ﹤0.01% 2989
2023
Q3
$8.36M Buy
282,400
+128,800
+84% +$4.32M 0.01% 1069
2023
Q2
$5.42M Buy
153,600
+53,600
+54% +$1.5M ﹤0.01% 1304
2023
Q1
$2.41M Buy
+100,000
New +$2.32M ﹤0.01% 2053

Other funds holding CFLT

Barclays's CFLT Position: Q1 2026 in Review

Barclays sold out of Confluent (CFLT) in Q1 2026, closing a stake of 84,669 shares — an estimated $2.56M sold.

Barclays first reported a position in CFLT in Q1 2022 and held it in 16 quarters. The position peaked at $28.8M in Q4 2022. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Barclays reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 84,669 Confluent shares in Q1 2026, an estimated $2.56M.
  • Barclays first reported a position in Confluent in Q1 2022 and held it in 16 quarters.
  • Barclays's Confluent position peaked at $28.8M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.